KBC Group NV lessened its holdings in Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 90.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,234 shares of the company's stock after selling 41,947 shares during the quarter. KBC Group NV's holdings in Ryan Specialty were worth $313,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Raymond James Financial Inc. bought a new position in Ryan Specialty in the fourth quarter valued at approximately $94,484,000. Norges Bank acquired a new position in shares of Ryan Specialty in the 4th quarter valued at $78,358,000. Millennium Management LLC boosted its position in shares of Ryan Specialty by 1,111.4% in the 4th quarter. Millennium Management LLC now owns 1,174,086 shares of the company's stock worth $75,329,000 after purchasing an additional 1,077,169 shares during the last quarter. CIBC Private Wealth Group LLC boosted its position in shares of Ryan Specialty by 6,911.0% in the 4th quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company's stock worth $48,036,000 after purchasing an additional 774,718 shares during the last quarter. Finally, Artemis Investment Management LLP acquired a new stake in shares of Ryan Specialty during the first quarter worth $57,023,000. Institutional investors and hedge funds own 84.82% of the company's stock.
Insiders Place Their Bets
In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,377 shares of the business's stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $65.84, for a total transaction of $946,581.68. Following the sale, the executive vice president directly owned 1,117 shares of the company's stock, valued at $73,543.28. The trade was a 92.79% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director David P. Bolger sold 5,000 shares of Ryan Specialty stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the completion of the sale, the director directly owned 71,467 shares in the company, valued at approximately $5,059,863.60. This represents a 6.54% decrease in their position. The disclosure for this sale can be found here. 52.21% of the stock is currently owned by company insiders.
Analyst Ratings Changes
Several equities analysts have weighed in on RYAN shares. Wells Fargo & Company cut their target price on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. Keefe, Bruyette & Woods cut their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Barclays decreased their price objective on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a report on Friday, April 11th. TD Cowen initiated coverage on shares of Ryan Specialty in a research note on Thursday, April 10th. They issued a "buy" rating and a $89.00 target price for the company. Finally, The Goldman Sachs Group raised shares of Ryan Specialty from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $74.00 to $81.00 in a research report on Tuesday, May 13th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $75.58.
Check Out Our Latest Report on Ryan Specialty
Ryan Specialty Price Performance
RYAN stock opened at $66.18 on Friday. The stock has a 50-day moving average price of $68.07 and a two-hundred day moving average price of $68.09. Ryan Specialty Holdings Inc. has a 1 year low of $55.67 and a 1 year high of $77.16. The stock has a market cap of $17.37 billion, a PE ratio of 194.65, a price-to-earnings-growth ratio of 1.78 and a beta of 0.66. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 3.45.
Ryan Specialty (NYSE:RYAN - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.39 EPS for the quarter, meeting the consensus estimate of $0.39. The firm had revenue of $690.17 million for the quarter, compared to analysts' expectations of $680.80 million. Ryan Specialty had a return on equity of 47.70% and a net margin of 6.97%. The business's quarterly revenue was up 25.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.35 EPS. Equities analysts forecast that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.
Ryan Specialty Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 0.73%. The ex-dividend date of this dividend was Tuesday, May 13th. Ryan Specialty's payout ratio is 141.18%.
Ryan Specialty Company Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report